James B Bucher's Net Worth
$467 Thousand
Who is James B Bucher?
James B Bucher does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, and Eliem Therapeutics, Inc..
SEC CIK
James B Bucher's CIK is 0001664928
Past Insider Trading and Trends
2019 was James B Bucher's most active year for acquiring shares with 5 total transactions. James B Bucher's most active month to acquire stocks was the month of September. 2019 was James B Bucher's most active year for disposing of shares, totalling 8 transactions. James B Bucher's most active month to dispose stocks was the month of September. 2018 saw James B Bucher paying a total of $21,252.55 for 142,273 shares, this is the most they've acquired in one year. In 2019 James B Bucher cashed out on 484,574 shares for a total of $524,466.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALDER BIOPHARMACEUTICALS INC No price found
EVP & General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -9.81K |
$13.60 | -$477,499.23 |
0
|
May 31 - Oct 22
| |||
Form 4
| +151.77% | 5.91K |
$13.85 | -$26,280.85 | 9.81K |
Scheduled
|
Apr 23 - Apr 25
| ||
Form 4
| +7.54% | 273 |
$9.35 | $2,552.55 | 3.9K |
Nov 30 - Feb 6
| |||
Form 4
| +123.23% | 2K |
$9.35 | $18,700.00 | 3.62K |
May 31 - Nov 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
∞
| 1.62K |
$9.35 | $15,175.05 | 1.62K |
Nov 30 - Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eliem Therapeutics, Inc. (ELYM) Snapshot price: $2.62
EVP and General Counsel
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) No price found
Chief Legal Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||